Advertisement

Pallium

, Volume 20, Issue 2, pp 24–27 | Cite as

Medicinale cannabis

Eén van de behandelingsopties in de palliatieve zorg
  • Maurice van der Vorst
Onderzoek
  • 95 Downloads

Samenvatting

Pijn, misselijkheid, slechte eetlust, gewichtsverlies en angst zijn veelvoorkomende klachten van patiënten in de palliatieve fase. Medicinale cannabis is één van de behandelingsopties om deze klachten te verminderen. De wetenschappelijke bewijsvoering voor het gebruik van deze middelen in de palliatieve zorg is echter vaak niet goed onderbouwd. In dit artikel bespreken we de werkzaamheid en bijwerkingen van medicinale cannabis bij gebruik in de palliatieve zorg nader.

Literatuur

  1. 1.
    World drug report. New York: United Nations, Office on Drugs and Crime; 2017.Google Scholar
  2. 2.
    Mechoulam R. The pharmacohistory of Cannabis sativa. In: Mechoulam R, editor. Cannabinoids as therapeutic agents. Boca Raton (FL): CRC Press; 1986. p. 1-19.Google Scholar
  3. 3.
    Zhornitsky S, Potvin S. Cannabidiol in humans — The quest for therapeutic targets. Pharmaceuticals 2012; 5: 529-552.Google Scholar
  4. 4.
    Medicinale Cannabis Informatiebrochure voor artsen en apothekers. https://www.cannabisbureau.nl/medicinale-cannabis/informatie-en-brochures.
  5. 5.
  6. 6.
    Grotenhermen F, Berger M, Gebhardt K. Cannabidiol. Solothurn: Nachtschatten; 2015.Google Scholar
  7. 7.
    Whiting PF, Wolff RF, Deshpande S et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. 2015; 313: 2456-2473.Google Scholar
  8. 8.
    Mücke M, Carter C, Cuhls H et al. Cannabinoids in palliative care: Systematic review and meta-analysis of efficacy, tolerability and safety. Schmerz. 2016; 30: 25-36.Google Scholar
  9. 9.
    Brisbois TD, de Kock IH, Watanabe SM et al. Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Ann Oncol. 2011; 22: 2086-2093.Google Scholar
  10. 10.
    Jatoi A, Windschitl HE, Loprinzi CL et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol. 2002; 20: 567–573.Google Scholar
  11. 11.
    Johnson JR, Burnell-Nugent M, Lossignol D et al. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010; 39: 167–179.Google Scholar
  12. 12.
    Portenoy RK, Ganae-Motan ED, Allende S et al. Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain. 2012; 13: 438–449.Google Scholar
  13. 13.
    Strasser F. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. 2006; J Clin Oncol 24: 3394–3400.Google Scholar
  14. 14.
    Abrams DI, Hilton JF, Leiser RJ et al. Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med. 2003; 139: 258–266.Google Scholar
  15. 15.
    Beal JE, Olson R, Laubenstein L et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. 1995; J Pain Symptom Manage 10: 89–97.Google Scholar
  16. 16.
    Timpone JG, Wright DJ, Li N et al. The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. AIDS Res Hum Retroviruses. 1997; 13: 305–315.Google Scholar
  17. 17.
    Volicer L, Stelly M, Morris J et al. Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer’s disease. Int J Geriatr Psychiatry, 1997; 12 :913-919.Google Scholar
  18. 18.
    https://www.zorginstituutnederland.nl/. Verkenning naar mogelijke herbeoordeling medicinale cannabis pdf.

Copyright information

© Bohn Stafleu van Loghum is een imprint van Springer Media B.V., onderdeel van Springer Nature 2018

Authors and Affiliations

  • Maurice van der Vorst
    • 1
  1. 1.internist-oncoloog, medisch consulent palliatieve zorg bij het Ziekenhuis Rijnstate ArnhemVU medisch centrumAmsterdamNederland

Personalised recommendations